Evidence for Autocrine Basis of Transformation in NIH-3T3 Cells Transfected with met/HGF Receptor Gene

References

• Aaronson S. Growth factors and cancer. Science 1991; 254: 1146–1153
   PubMed Web of Science ®Google Scholar
• Betsholtz C., Johnson A., Heldin C.-H., Westermark B., Lind P., Urdea M. S., Eddy R., Shows T. B., Philpott K., Mellor A. L., Knott T. J., Scott J. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumor cell lines. Nature 1986; 320: 695–699
   PubMed Web of Science ®Google Scholar
• Bhargava M., Joseph A., Knesel J., Halaban R., Li Y., Pang S., Goldberg I., Setter E., Donovan M. A., Zarnegar R., Michalopoulos G., Nakamura T., Faletto D., Rosen E. M. Scatter factor and hepatocyte growth factor: activities, properties, and mechanisms. Cell Growth Diff. 1992; 3: 11–20
   PubMedGoogle Scholar
• Bottaro D. P., Rubin J. S., Faletto D. L., Chan A. M.-L., Kmiecik T. E., Van de Woude G. F., Aaronson S. A. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 1991; 251: 802–804
   PubMed Web of Science ®Google Scholar
• Bouck N. Tumor angiogenesis: The role of oncogenes and tumor suppressor genes. Cancer Lett. 1990; 2: 179–185
   Google Scholar
• Cantley L. C., Augar K. R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell 1991; 64: 281–302
   PubMed Web of Science ®Google Scholar
• Coffey R. J. J., Leof E. B., Shipley G. D., Moses H. L. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell. Physiol. 1987; 132: 143–148
   PubMed Web of Science ®Google Scholar
• Cuttitta F., Carney D. N., Mulshine J., Moody T. W., Fedorko J., Fischler A., Minnna J. D. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature 1985; 216: 823–826
   Google Scholar
• Dernyck R., Goeddel D. V., Ullrich A., Gutterman J. U., Williams R. D., Bringman T. S., Berger H. Synthesis of messenger RNAs for transforming growth factors a and b and the epidermal growth factor receptor by human tumors. Cancer Res. 1987; 47: 707–712
   Google Scholar
• Di Fiore P. P., Pierce J. H., Fleming T. P., Hazan R., Ullrich A., King C. R., Schlessinger J., Aaronson S. A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH/3T3 cells. Cell 1987; 5: 1063–1070
   Google Scholar
• Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 1992; 267: 10931–10934
   PubMed Web of Science ®Google Scholar
• Furlong R. A., Takehara T., Taylor W. G., Nakamura T., Rubin J. S. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J. Cell Sci. 1991; 100: 173–177
   PubMed Web of Science ®Google Scholar
• Good D. J., Polverini P. J., Rastinejad F., Le Beau M. M., Lemons R. S., Frazier W. A., Bouck N. P. A tumor suppressor-dependent inhibition of angiogenesis is immunologically and functionally indistinguishable from a fragment of thromobospondin. Proc. Natl Acad. Sci. USA 1990; 87: 6624–6628
   PubMed Web of Science ®Google Scholar
• Hiraoka D., Nakamura N., Nishizawa Y., Uchida N., Noguchi S., Matsumoto K., Sato B. Inhibitory and stimulatory affects of glucocorticoid on androgen-induced growth of murine Shiogi carcinoma 115 in vivo and in cell culture. Cancer Res. 1987; 47: 6558–6564
   Google Scholar
• Iyer A., Kmiecik T. E., Park M., Daar I., Blair D., Dunn K. J., Sutrave P., Ihle J. N., Bedescot M., Vande Woude G. F. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Diff. 1990; 1: 87–95
   PubMedGoogle Scholar
• Johnson M., Koukolis G., Matsumoto K., Nakamura T., Iyer A. Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hematology 1993; 17: 1052–1061
   Google Scholar
• Kan M., Zhang G., Zarnegar R., Michalopoulos G., Myoken Y., McKeehan W. L., Steevens J. I. Hepatocyte growth factor/hepatopoietin A stimulate the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorge dependent growth of SV-40 transformed RPTE. Biochem. Biophys. Res. Commun. 1991; 174: 331–337
   PubMed Web of Science ®Google Scholar
• Kochhar K. S., Linnekin D., Iyer A. P. PDGF-independent activation of PDGF-β receptors in NIH-3T3 cells transformed by c-met protooncogene. Exp. Cell REs. 1994; 212: 414–421
   Google Scholar
• La Rocca R., Danesi R., Cooper M. M., Janis-Dow C., Ewing M., Linehan M., Prebois C. Effect of suramin on human prostrate cancer cells in vitro. J. Urol. 1991; 145: 393
   PubMed Web of Science ®Google Scholar
• La Rocca R. V., Stein C. A., Myers C. E. Suramin: Prototype of a new generation of antitumor compounds. Cancer cells 1990; 2: 106–115
   PubMed Web of Science ®Google Scholar
• Libemann T. A., Friesel R., Jaye M., Lyall R. M., Westermark B., Drohan W., Schmidt A., Maciag T., Schlessinger J. An angiogenic growth factor is expressed in human glioma cells. EMBO J. 1987; 6: 1627–1632
   PubMedGoogle Scholar
• Linch D. C., Wallace D. L., O'Flynn K. Signal transduction in T-lymphocytes. Immunol. Rev. 1987; 95: 137–159
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E., Sambrook J. Molecular cloning: A Laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1982
   Google Scholar
• Matsumoto K., Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncogeneis 1992; 3: 27–54
   PubMedGoogle Scholar
• Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901–908
   PubMed Web of Science ®Google Scholar
• Morimoto A., Tada K., Nakayama Y., Kohno K., Naito S., Ono M., Kuwano M. Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells. Jap. J. Cancer Res. 1994; 85: 53–62
   Google Scholar
• Naidu Y. M., Rosen E. M., Zitnick R., Goldberg I., Park M., Naujokas M., Polverini P. J., Nickoloff B. J. Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc. Natl Acad. Sci. USA 1994; 91: 5281–5285
   PubMed Web of Science ®Google Scholar
• Nakamura T., Nawa K., Ichihara A., Kaise A., Nishino T. Purification and subunit structure of hepatocyte growth factor in rat platelets. FEBS Lett. 1987; 224: 311–316
   PubMed Web of Science ®Google Scholar
• Peehl D., Wong S, Stamey T. Cytostatic effects of suramin on prostrate cancer cells cultured from primary tumors. J. Urol. 1991; 145: 624
   Google Scholar
• Pierce J. H., Ruggiero M., Fleming T. P., Di Fiore P. P., Greenberger J. S., Varticovski L., Schlessinger J., Rivera G., Aaronson S. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science 1988; 239: 628–631
   PubMed Web of Science ®Google Scholar
• Pollak M., Richard M. Suramin blockade of insulin like growth factor I-stimulated proliferation of human osteosarcoma cells. J. Natl Cancer Inst. 1990; 82: 1349–1352
   PubMed Web of Science ®Google Scholar
• Riedel H., Massozlia S., Schlessinger S., Ullrich A. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH/3T3 mouse fibroblasts. Proc. Natl. Acad. Sci. USA 1988; 85: 1477–1481
   PubMed Web of Science ®Google Scholar
• Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson A., Vande Woude G. F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell Biol. 1992; 12: 5152–5158
   PubMed Web of Science ®Google Scholar
• Rong S., Oskarsson M., Faletto D., Tsarfaty I., Resau J. H., Nakamura T., Rosen E., Hopkis R. F., Vande Woude G. F. Tumorigeneis induced by coexpression of human hepatocyte growth factor and the human met proto-oncogene leads to higher levels of expression of the ligand and receptor. Cell Growth Diff. 1993; 4: 563–569
   PubMedGoogle Scholar
• Rosen E. M., Grant D. S., Kleinman H., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P. Scatter factor (hepatocyte growth factor) is potent angiogenic factor in-vivo. Symp. Soc. Exp. Biol. 1993; 47: 227–234
   Google Scholar
• Roussel M. F., Dull T. J., Rettenmier C. W., Ralph P., Ullrich, Sherr C. J. Transforming potential of the c-fms protooncogene (CSF-1 receptor). Nature (London) 1987; 325: 549–552
   PubMed Web of Science ®Google Scholar
• Rubin J. S., Chan A. M., Bottaro D. P., Burgess W. H., Taylor W. G., Cech A. C., Hirschfield D. W., Wong J., Miki T., Finch P. W., Aaronson A. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Natl Acad. Sci. USA 1991; 88: 415–419
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Ullrich A. Growth factor signalling by receptor tyrosine kinases. Neuron 1992; 9: 383–391
   PubMed Web of Science ®Google Scholar
• Sporn M. B, Roberts A. B. Autocrine growth factors and cancer. Nature 1985; 313: 747–754
   Web of Science ®Google Scholar
• Stein C. A., La Rocca R. V., Thomas R., McAtee N., Myers C E. Suramin: An anticancer drug with a unique mechanism of action. J. Clin. Oncol. 1989; 7: 499–508
   PubMed Web of Science ®Google Scholar
• Stoker M, Gherardi E. Regulation or cell movement: the motogenic cytokines. Biochim. Biophys. Acta. 1991; 1072: 81–102
   PubMed Web of Science ®Google Scholar
• Todaro G. J., DeLarco J. E. Growth factors produced by sarcoma virus-transformed cells. Cancer Res. 1978; 38: 4147–4154
   PubMed Web of Science ®Google Scholar
• Thompson T. C., Southgate I., Kitchener G., Land H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 1989; 56: 917–930
   PubMed Web of Science ®Google Scholar
• Tolsma S. A., Volpert O. V., Good D. J., Frazier W. A., Polverini P. J., Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell. Biol. 1993; 122: 497–511
   PubMed Web of Science ®Google Scholar
• Vassbotn F. S., Ostman A., Langeland N., Holmsen H., Westmark B., Heldin C-H., Nister M. Activated platelet-derived growth factor autocrine pathways drives the transformed phenotype of human glioblastoma cell line. J. Cell. Physiol. 1994; 158: 381–389
   PubMed Web of Science ®Google Scholar
• Yarden Y., Weinberg R. A. Experimental approaches to hypothetical hormones: Detection of a candidate ligand of the neu protooncogene. Proc. Natl Acad. Sci. USA 1989; 86: 3179–3183
   PubMed Web of Science ®Google Scholar